LucyRx Acquires CerpassRx from Nomi Health

October 2, 2025

LucyRx, a next-generation pharmacy benefit manager (PBM), signed and later completed its acquisition of CerpassRx to strengthen clinical capabilities and expand access to prescription care. The deal combines CerpassRx’s cost-containment and service model with LucyRx’s technology-driven clinical approach and AI platform.

Buyers
LucyRx
Targets
CerpassRx
Sellers
Nomi Health
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.